Edgewise Therapeutics Inc (EWTX)

Jan 06, 2026

Edgewise Therapeutics CEO to outline 2026 goals at JPMorgan event - Traders Union

Jan 06, 2026

Jan 06, 2026

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 61.93% Upside Potential in Biotech - DirectorsTalk Interviews

Jan 06, 2026

Jan 06, 2026

Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 - PR Newswire

Jan 06, 2026

Jan 05, 2026

Edgewise Therapeutics reports inducement grants as permitted by the Nasdaq Listing Rules - marketscreener.com

Jan 05, 2026

Jan 05, 2026

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - PR Newswire

Jan 05, 2026

Jan 03, 2026

H.C. Wainwright Maintains a Buy on Edgewise Therapeutics (EWTX), Sets a $42 PT - MSN

Jan 03, 2026

Jan 02, 2026

Aug Ideas: Can Edgewise Therapeutics Inc stock hit record highs againWeekly Investment Report & Momentum Based Trading Signals - moha.gov.vn

Jan 02, 2026

Dec 31, 2025

Why Edgewise Therapeutics stock rocked the market today - MSN

Dec 31, 2025

Dec 31, 2025

Edgewise Therapeutics (EWTX) Stock News, Forecasts and Analysis: What’s Driving the December 2025 Move and What Comes Next - ts2.tech

Dec 31, 2025

Dec 31, 2025

Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge - ts2.tech

Dec 31, 2025

Dec 30, 2025

Edgewise rises on mid-stage trial data for heart disease therapy - MSN

Dec 30, 2025

Dec 30, 2025

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX - ts2.tech

Dec 30, 2025

Dec 30, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap DownHere's What Happened - MarketBeat

Dec 30, 2025

Dec 30, 2025

Analysts Are Bullish on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Edgewise Therapeutics (EWTX) - The Globe and Mail

Dec 30, 2025

Dec 30, 2025

Valuation Update: Is Edgewise Therapeutics Inc stock a top pick in earnings seasonMarket Trend Report & Verified Entry Point Detection - moha.gov.vn

Dec 30, 2025

Dec 29, 2025

This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits - The Globe and Mail

Dec 29, 2025

Dec 29, 2025

Edgewise: Maintaining Buy On Part D EDG-7500 Data And Next Q2 2026 Catalyst (NASDAQ:EWTX) - Seeking Alpha

Dec 29, 2025

Dec 29, 2025

What drives Edgewise Therapeutics Inc stock priceHigh Dividend Yield Stocks & Free Trading Signals to Sharpen Your Edge - earlytimes.in

Dec 29, 2025

Dec 27, 2025

HC Wainwright says Edgewise data reinforces EDG-7500 potential differentiation - MSN

Dec 27, 2025

Dec 27, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Cut to Sell at Wall Street Zen - MarketBeat

Dec 27, 2025

Dec 27, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 27, 2025

Dec 26, 2025

Edgewise Therapeutics (EWTX) Stock Today: EDG-7500 Safety Update, Analyst Targets, and What Investors Are Watching Next - ts2.tech

Dec 26, 2025

Dec 26, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 5.2%Here's Why - MarketBeat

Dec 26, 2025

Dec 26, 2025

Edgewise Therapeutics (EWTX) Stock Surges on EDG-7500 Safety Update as Wall Street Prepares to Reopen After Christmas - ts2.tech

Dec 26, 2025

Dec 26, 2025

Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study - MSN

Dec 26, 2025

Dec 25, 2025

Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy - BioSpace

Dec 25, 2025

Dec 25, 2025

Edgewise Therapeutics Stock Jumps After Trial Update For Genetic Heart Disease — Wall Street Eyes A Potential Standout - Stocktwits

Dec 25, 2025

Dec 25, 2025

Edgewise Therapeutics (EWTX): Assessing Valuation After an 80% Three-Month Surge in the Share Price - Yahoo Finance

Dec 25, 2025

Dec 25, 2025

Edgewise Stock (+26%): Phase 2 HCM Safety Data Forces a Re-Rate - Trefis

Dec 25, 2025

Dec 24, 2025

Why Edgewise Therapeutics Stock Rocked the Market Today - Finviz

Dec 24, 2025

Dec 24, 2025

Why Edgewise Therapeutics Stock Rocked the Market Today - The Motley Fool

Dec 24, 2025

Dec 24, 2025

Edgewise Therapeutics: Differentiated EDG-7500 Profile, Late-Stage Cardiology Catalyst, and Expanding Pipeline Support Buy Rating - TipRanks

Dec 24, 2025

Dec 24, 2025

Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts - ts2.tech

Dec 24, 2025

Dec 24, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap UpHere's What Happened - MarketBeat

Dec 24, 2025

Dec 24, 2025

Edgewise Therapeutics rises on positive safety data from heart disease drug trial - TradingView — Track All Markets

Dec 24, 2025

Dec 24, 2025

Edgewise posts trial data for heart disease drug (EWTX:NASDAQ) - Seeking Alpha

Dec 24, 2025

Dec 24, 2025

Edgewise Therapeutics Shares Rise After Advancing Phase 2 Hypertrophic Cardiomyopathy Trial - marketscreener.com

Dec 24, 2025

Dec 24, 2025

Why Is Edgewise Therapeutics Stock Soaring Wednesday?Edgewise Therapeutics (NASDAQ:EWTX) - Benzinga

Dec 24, 2025

Dec 24, 2025

Edgewise reports positive interim safety data for HCM drug EDG-7500 - Investing.com Nigeria

Dec 24, 2025

Dec 24, 2025

Edgewise Therapeutics stock rises on positive HCM drug update By Investing.com - Investing.com Nigeria

Dec 24, 2025

Dec 24, 2025

Edgewise Therapeutics stock rises on positive HCM drug update - Investing.com

Dec 24, 2025

Dec 24, 2025

Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRU - GuruFocus

Dec 24, 2025

Dec 24, 2025

Edgewise Completed Phase 2 CIRRUS-HCM Parts B And C, Reports Favorable Interim Safety From Part D - Nasdaq

Dec 24, 2025

Dec 24, 2025

Edgewise Therapeutics Completes Parts B and C of Phase 2 Hypertrophic Cardiomyopathy Trial - marketscreener.com

Dec 24, 2025

Dec 24, 2025

Edgewise reports positive interim safety data for HCM drug EDG-7500 By Investing.com - Investing.com South Africa

Dec 24, 2025